Buscar
-
Myocarditis and Pericarditis in Adolescents after First and Second doses of mRNA COVID-19 Vaccines
(European Heart Journal. Quality of Care and Clinical Outcomes. vol. 8, n° 2, pp. 99-103, 2022-03)Article de revue -
Association study between herpes zoster reporting and mRNA COVID‐19 vaccines (BNT162b2 and mRNA‐1273)
(British Journal of Clinical Pharmacology. vol. 88, n° 7, pp. 3529-3534, 2022-07)Article de revue -
Conceiving, conducting, reporting, interpreting, and publishing disproportionality analyses: A call to action
(British Journal of Clinical Pharmacology, 2022-02-17)Article de revue -
Antipsychotics and risk of QT prolongation: a pharmacovigilance study
(Psychopharmacology. vol. 240, pp. 199-202, 2022-12-14)Article de revue -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre acceso -
Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
(Frontiers in Psychiatry. vol. 13, 2022-07-01)Article de revueLibre acceso -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueLibre acceso -
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
(Therapies. vol. 78, n° 1, pp. 115-129, 2022-11-25)Article de revue